These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6366109)

  • 1. Effect of the degree of hyperglycaemia on the catalytic activities of glycosidases in kidney and urine of diabetic rats.
    Juretić D; Lipovac K; Hadzija M; Slijepcević M
    J Clin Chem Clin Biochem; 1984 Jan; 22(1):21-7. PubMed ID: 6366109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in glycohydrolase activities in streptozotocin-diabetic Chinese hamsters (Cricetulus griseus).
    Chang AY; Perry CS; Wyse BM
    Comp Biochem Physiol B; 1979; 63(3):341-4. PubMed ID: 318416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of insulin on maltase and N-acetyl-beta-D-glucosaminidase (NAG) activities of serum and kidney in experimental diabetic rats].
    Iizuka Y; Sakurai E; Hikichi N; Niwa H
    Nihon Yakurigaku Zasshi; 1989 Aug; 94(2):129-35. PubMed ID: 2530141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosidase activities in the liver and kidney of hereditary diabetic mice.
    Fushimi H; Shibata M; Tarui S
    J Biochem; 1980 Mar; 87(3):941-9. PubMed ID: 7390971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of intestinal and renal alpha-glycosidases to alloxan and streptozotocin-induced diabetes: a comparative study.
    Sharma SD; Sivakami S
    Biochem Mol Biol Int; 1998 Apr; 44(4):647-56. PubMed ID: 9584978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal enzymes are decreased in the kidney of diabetic rats.
    Peres GB; Juliano MA; Simões MJ; Michelacci YM
    Biochim Biophys Acta; 2013 Jan; 1832(1):85-95. PubMed ID: 23032151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tobramycin and gentamicin on the activity of some glycosidases in rat serum and urine.
    Sanchez-Bernal MC; Martin-Barrientos J; Cabezas JA
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 79(2):401-5. PubMed ID: 6151473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat-urine glycosidases and kidney damage.
    Robinson D; Price RG; Dance N
    Biochem J; 1967 Feb; 102(2):533-8. PubMed ID: 6029612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymuria in streptozotocin-diabetic rats.
    Grötsch H; Hropot M; Kief H; Klaus E
    J Clin Chem Clin Biochem; 1986 Aug; 24(8):533-9. PubMed ID: 3531386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-glycosidases and diabetic microangiopathy. I. Decreases of beta-glycosidase activities in diabetic rat kidney.
    Fushimi H; Tarui S
    J Biochem; 1976 Feb; 79(2):265-70. PubMed ID: 131796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valibose, an alpha-glucosidase inhibitor, ameliorates the metabolic disorder of glucose and lipids and the nephropathy in streptozotocin-induced diabetic rats].
    Liu Q; Liu SN; Sun SJ; Shen ZF
    Yao Xue Xue Bao; 2013 Aug; 48(8):1227-32. PubMed ID: 24187828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of Lysosomal Enzymes in Alloxan-Induced Diabetes in the Mouse.
    Witek B; Rochon-Szmejchel D; Stanisławska I; Łyp M; Wróbel K; Zapała A; Kamińska A; Kołątaj A
    Adv Exp Med Biol; 2018; 1040():73-81. PubMed ID: 28905270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of renal hypertrophy and increased renal Na,K-ATPase in streptozotocin-diabetic rats.
    Ku DD; Sellers BM; Meezan E
    Endocrinology; 1986 Aug; 119(2):672-9. PubMed ID: 3015553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the mechanism of increases in serum -glucuronidase and N-acetyl- -glucosaminidase activities in diabetes mellitus. II. Experiments with alloxan induced diabetic rats].
    Noguchi H
    Sapporo Igaku Zasshi; 1970; 38(5):234-46. PubMed ID: 5535643
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment.
    Rasch R; Dørup J
    Diabetologia; 1997 Jul; 40(7):802-9. PubMed ID: 9243101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the catalytic activities of proteoglycan-degrading lysosomal enzymes in parenchymal and non-parenchymal liver cells and in serum during the development of experimental liver fibrosis.
    Weber W; Kehrer T; Gressner AM; Stuhlsatz HW; Greiling H
    J Clin Chem Clin Biochem; 1983 May; 21(5):287-93. PubMed ID: 6875476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolase activities in the rat aorta. I. Effects of diabetes mellitus and insulin treatment.
    Wolinsky H; Goldfischer S; Capron L; Capron F; Coltoff-Schiller B; Kasak L
    Circ Res; 1978 Jun; 42(6):821-31. PubMed ID: 148980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of renal hypertrophy and elevated renal Na+,K+-ATPase activity after insulin treatment in streptozotocin-diabetic rats.
    Ku DD; Roberts RB; Sellers BM; Meezan E
    Endocrinology; 1987 May; 120(5):2166-73. PubMed ID: 3032576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the nephrotoxicity of p-nitrophenylarsonic acid: changes in rat kidney and urinary enzyme activities following the administration of p-nitrophenylarsonic acid.
    Price RG
    Chem Biol Interact; 1979 Feb; 24(2):241-55. PubMed ID: 218743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate contents, and glycosidase and glycosyl transferase activities in tissues from streptozotocin diabetic mice.
    Serrano MA; Cabezas JA; Reglero A
    Comp Biochem Physiol B; 1985; 80(3):629-32. PubMed ID: 3924473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.